Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 12.9B | 12.7B | 12.0B | 11.5B |
Cost of revenue | 2.2B | 2.2B | 2.3B | 2.1B |
Gross profit | 10.8B | 10.5B | 9.7B | 9.4B |
Operating expense | ||||
Research & development | 3.0B | 2.8B | 3.1B | 2.6B |
Selling general and admin | 5.1B | 4.6B | 4.0B | 4.9B |
Other operating expenses | — | — | — | -70M |
Operating income | 2.7B | 3.1B | 2.0B | 2.0B |
Non operating interest income | ||||
Income | 100M | 111M | 65M | 101M |
Expense | 443M | 413M | 408M | 392M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 2.8B | 897M | 1.7B |
Tax provision | 469M | 620M | -62M | 274M |
Net income | 1.9B | 2.2B | 959M | 1.4B |
Basic EPS | 1.2 | 1.4 | 0.6 | 0.9 |
Diluted EPS | 1.2 | 1.4 | 0.6 | 0.9 |
Basic average shares | 2.0B | 2.0B | 2.0B | 2.0B |
Diluted average shares | 2.0B | 2.0B | 2.0B | 2.0B |
EBITDA | 4.1B | 4.5B | 2.9B | 3.3B |
Net income from continuing op. | 2.4B | 2.8B | 897M | 1.7B |
Minority interests | -1M | -1M | 1M | -4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |